> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Establish Regulatory Pathway for CBD Supplements: Petition
- URL: https://www.fdaweb.com/establish-regulatory-pathway-for-cbd-supplements-petition/
- Published: 2020-06-17T12:00:00.000Z
- Updated: 2026-09-14T16:18:39.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147026

The Council for Responsible Nutrition (CRN) is asking FDA to establish a regulatory pathway to legally market dietary supplements containing hemp-derived cannabidiol (CBD). The 6/16 [petition](https://files.constantcontact.com/0ac3ac29601/2d7697a9-0efe-4920-bbe3-f44e0e633923.pdf?ref=fdaweb.com) says Congress and industry have repeatedly requested that FDA use the authority granted to it by Congress to allow CBD to be a legal ingredient in dietary supplements, consistent with the intent of Congress in legalizing hemp. “If ever there was an appropriate time for FDA to use this authority,” the petition says, “the time is now.”

CRN says the agency has represented that it has been actively exploring the use of its authority to legalize CBD as a dietary supplement ingredient. Despite holding a 5/31/19 public meeting to better understand hemp-derived substances and how they should be regulated, it says, FDA has taken no steps to create a legal pathway, other than to make vague statements that the agency “is actively evaluating potential rulemaking to allow CBD in dietary supplements.”

The petition asks that FDA: 

- exercise its statutory authority and discretion to issue a regulation finding that hemp-derived CBD is a lawful dietary ingredient;
- provide guidance clarifying when a substance is considered “an article” as that term is used in the applicable law; and
- enforce existing dietary supplement regulations already promulgated in the Federal Food, Drug, and Cosmetic Act and other laws with respect to hemp-derived CBD products being marketed as dietary supplements.